Document is current
Any future updates will be listed below
-
Authors
Gong, Rong
Wan, Xiaoya
Jiang, Shilong
Guan, Yidi
Li, Yizhi
Jiang, Ting
Chen, Zonglin
Zhong, Changxin
He, Linhao
Xiang, Zhongyuan
Yang, Junya
Xu, Biao
Yang, Jinming https://orcid.org/0000-0003-4511-3327
Cheng, Yan https://orcid.org/0000-0002-7905-0443
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82373064, 81972480)
Natural Science Foundation of Hunan Province (2022JJ80106)
the Project of Innovation-driven Plan in Central South University
- License Information
-
More Information
Article History
Received: 8 October 2024
Revised: 6 May 2025
Accepted: 12 May 2025
First Online: 20 May 2025
Competing interests
: The authors declare that they have no competing interests.
: All the animal experiments were approved by the Ethics Committee of the Department of Laboratory Animals of Central South University (code/CSU-2022-0001-0029), and the animal protocol was in accordance with the institutional guidelines of the Animal Care and Use Committee of Central South University. The maximal tumor burden allowed by ethics did not exceed 2000 mm3. The ethical endpoint was determined once the maximal tumor burden was reached. All the experiments performed with human specimens were reviewed and approved by the Research Ethics Board at the Second Xiangya Hospital for Cancer Research (code/2023-0233). All patients whose tumor samples were used in the study gave informed consent.
